[99] A person with cobalamin C disease, a rare autosomal, recessive, inheritance disease which results in combined methylmalonic aciduria and homocystinuria), [100] can be treated with intravenous or intramuscular hydroxocobalamin
While ongoing research underscores its potential as a breakthrough in regenerative therapy, further human trials are essential to fully elucidate its long-term safety, efficacy, and clinical applications.
Tissue repair research peptides are reference compounds studied in preclinical models of wound healing, tendon and ligament repair, and gut mucosal protection with BPC-157 and TB-500 as the two most investigated reagents in this space
Unlike BPC-157, injection site for TB-500 is less critical since it acts systemically
Some users take BPC-157 products on an ongoing maintenance basis for gut health support